Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulating tumor suppressor genes: post-translational modifications
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 324

Showing 51-75 of 324 citing articles:

Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
Katherine M. Weh, Connor L. Howard, Yun Zhang, et al.
JCI Insight (2024)
Open Access | Times Cited: 7
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu, Shaoming Li, Xiaopeng Yin, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130351-130351
Closed Access | Times Cited: 6
FuncPhos-STR: An integrated deep neural network for functional phosphosite prediction based on AlphaFold protein structure and dynamics
Guangyu Zhang, Cai Zhang, Mingyue Cai, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131180-131180
Closed Access | Times Cited: 6
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark
Shanshan Zhao, Xue Zhang, Shuo Chen, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 46
TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer
María Paz Saldías, Diego Maureira, Octavio Orellana‐Serradell, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
Regulation of Inflammatory Cell Death by Phosphorylation
Wen Xu, Yi Huang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Post-translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature
James S. Clark, Rakez Kayed, Giulia Abate, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 25
Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy
Fanghua Chen, Junming Wang, Yingcheng Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
Alessia Garufi, Giuseppa Pistritto, Valerio D’Orazi, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 461-461
Open Access | Times Cited: 24
Lenvatinib resistance mechanism and potential ways to conquer
Wentao Bo, Yan Chen
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
Zaid Sirhan, Rawan Alojair, Anita Thyagarajan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2090-2090
Open Access | Times Cited: 14
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
Lara Planas‐Paz, Alicia Pliego‐Mendieta, Catherine Hagedorn, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 13
p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
Sergio Rius‐Pérez
Free Radical Biology and Medicine (2023) Vol. 207, pp. 183-193
Open Access | Times Cited: 13
Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade
Jiancheng Lv, Qikai Wu, Kai Li, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3744-3761
Open Access | Times Cited: 13
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression
Ya-Nan Pi, Qiushi Feng, Fusheng Sun, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 11, pp. 2382-2392
Open Access | Times Cited: 13
Enhanced innate responses in microglia derived from retinoblastoma patient‐specific iPSCs
Jia Xu, Si‐Jian Yu, Shuning Sun, et al.
Glia (2024) Vol. 72, Iss. 5, pp. 872-884
Closed Access | Times Cited: 5
Post‐translational modifications in diabetic cardiomyopathy
Zhi Li, Jie Chen, Hailong Huang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 5
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
Yuan Wang, Ineza Karambizi Sandrine, Li Ma, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 5
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1443-1443
Open Access | Times Cited: 5
The overview of lactylation in the placenta of preeclampsia
Qiaoli Feng, Ping Yang, Jinli Lyu, et al.
Placenta (2025) Vol. 160, pp. 135-143
Closed Access
The role of acetylation and deacetylation in cancer metabolism
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
AdipoR1 enhances the radiation resistance via ESR1/CCNB1IP1/cyclin B1 pathway in hepatocellular carcinoma cells
Yuhan Gan, Linhui Zhu, Yimo Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access

Scroll to top